Search

Your search keyword '"Barbini, B"' showing total 24 results
Start Over Author "Barbini, B" Publisher elsevier bv
24 results on '"Barbini, B"'

2. P.253 Immunoassay quantification and neuroimaging data for differentiating bipolar and unipolar depression: support vector machine on kernels and elastic net approaches

Author

Vai, B., primary, Parenti, L., additional, Cazzetta, S., additional, Mazza, M., additional, Bollettini, I., additional, Poletti, S., additional, Lorenzi, C., additional, Aggio, V., additional, Zanardi, R., additional, Barbini, B., additional, Colombo, C., additional, and Benedetti, F., additional

Published
2020
Full Text
View/download PDF

21. Optimized light therapy for non-seasonal major depressive disorder: Effects of timing and season

Author

Francesco Benedetti, Cristina Colombo, Chiara Gavinelli, Enrico Smeraldi, Mara Cigala Fulgosi, Barbara Barbini, Sara Dallaspezia, Dallaspezia, S, Benedetti, F, Colombo, C, Barbini, B, Fulgosi, Mc, Gavinelli, C, and Smeraldi, E

Subjects
Adult, Male, Light therapy, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Venlafaxine, Rating scale, Internal medicine, medicine, Humans, Circadian rhythm, Depression (differential diagnoses), Depressive Disorder, Major, Venlafaxine Hydrochloride, Middle Aged, Phototherapy, Cyclohexanols, medicine.disease, Combined Modality Therapy, Psychiatry and Mental health, Clinical Psychology, Endocrinology, Antidepressive Agents, Second-Generation, Major depressive disorder, Antidepressant, Female, Seasons, Analysis of variance, Psychology, medicine.drug
Abstract

"BACKGROUND:. Light Therapy (LT) when combined with standard antidepressant treatment for unipolar depression hastens recovery. We studied the influence of LT timing on the antidepressant efficacy of LT and the influence of the season of treatment and recurrence on the response to treatment.. METHODS:. We studied 70 inpatients affected by Unipolar Depression, treated for three weeks with combined LT and venlafaxine. Two-third of the patients received LT following a predictive algorithm based on MEQ scores; the others received LT at 11:00 a.m. Severity of depression was rated on the Hamilton Depression Rating Scale (HDRS). A subgroup of patients wore activity monitors.. RESULTS:. HDRS scores significantly decreased during treatment (Friedman's ANOVA: χ2=186.82, p

Published
2012

22. Dopaminergic augmentation of sleep deprivation effects in bipolar depression

Author

Francesco Benedetti, Barbara Barbini, Mara Cigala Fulgosi, Euridice Campori, Cristina Colombo, Benedetti, F, Campori, E, Barbini, B, Fulgosi, Mc, and Colombo, C

Subjects
Male, endocrine system, medicine.medical_specialty, Bipolar Disorder, Lithium (medication), Amineptine, Dibenzocycloheptenes, Placebo, Internal medicine, medicine, Humans, Bipolar disorder, Psychiatry, Biological Psychiatry, Dopaminergic, Middle Aged, medicine.disease, Psychiatry and Mental health, Sleep deprivation, Endocrinology, Mood, Dopamine Agonists, Sleep Deprivation, Antidepressant, Female, medicine.symptom, Psychology, Follow-Up Studies, medicine.drug
Abstract

Total sleep deprivation (TSD) has been used in association with lithium salts and with serotonergic and noradrenergic antidepressants, leading to sustained improvements in patients affected by major depression. Current theories on the neurobiological mechanism of action of TSD propose a major role for enhanced dopamine activity, To test the clinical relevance of dopaminergic enhancement in TSD, we treated a homogeneous sample of 28 bipolar depressed patients with three cycles of TSD combined with placebo or with the dopaminergic antidepressant amineptine. Changes in mood over time were rated with self-administered visual analogue scales and with the Montgomery-Asberg Depression Rating Scale. Patients showed improved mean daily-mood scores after TSD, an effect that was highest at the first cycle and decreased with treatment repetition. Amineptine enhanced the effects of TSD on perceived mood during the first two TSD cycles, but patients in the placebo and amineptine groups showed comparable results at the end of the treatment. Despite its theoretical importance, the clinical usefulness of combining TSD with a dopaminergic agent must be questioned. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.

Published
2001

23. The unipolar–bipolar dichotomy and the response to sleep deprivation

Author

Cristina Colombo, Laura Bellodi, Barbara Barbini, Enrico Smeraldi, Francesco Benedetti, Euridice Campori, Barbini, B, Colombo, C, Benedetti, F, Campori, E, Bellodi, L, and Smeraldi, E

Subjects
Adult, Male, endocrine system, medicine.medical_specialty, Bipolar Disorder, Time Factors, Diagnosis, Differential, Rating scale, mental disorders, medicine, Humans, Bipolar disorder, Psychiatry, Major depressive episode, Biological Psychiatry, Depression (differential diagnoses), Analysis of Variance, Depressive Disorder, Chi-Square Distribution, Depression, Discriminant Analysis, Middle Aged, medicine.disease, Psychiatry and Mental health, Sleep deprivation, Treatment Outcome, Mood, Disease Progression, Sleep Deprivation, Major depressive disorder, Female, medicine.symptom, Psychology, Mania
Abstract

Fifty-one inpatients affected by a major depressive episode were divided into four groups according to mood disorder diagnosis and previous clinical history (bipolar disorder type I; bipolar disorder type II; major depressive disorder with at least three previous depressive episodes; and single depressive episode patients) and administered three consecutive total sleep deprivation (TSD) cycles. Mood changes were rated with a reduced version of the Hamilton Depression Rating Scale and with self-administered visual analogue scales. TSD caused better clinical effects in bipolar and single-episode patients; in particular, unipolar patients lacked effects in perceived mood after the first TSD and showed worse Hamilton ratings in respect to the other groups after the three TSD treatments. Discriminant function analysis could correctly classify 80% of bipolar patients, post hoc, based on TSD response. Further researches on the clinical efficacy of TSD must take into account the heterogeneity of depression and of its biological substrate. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.

Published
1998

24. Prolactin concentrations after single and repeated oral doses of savoxepine in patients with chronic schizophrenia

Author

V. Brancato, B. Barbini, Roberto Cavallaro, M. Di Rosa, Enrico Smeraldi, Cavallaro, Roberto, Di Rosa, M, Barbini, B, Smeraldi, E, and Brancato, V.

Subjects
Pharmacology, medicine.medical_specialty, Savoxepine, business.industry, Prolactin, Psychiatry and Mental health, Endocrinology, Neurology, Internal medicine, medicine, Pharmacology (medical), Chronic schizophrenia, In patient, Neurology (clinical), business, Biological Psychiatry
Published
1991

Catalog

Books, media, physical & digital resources
See catalog results